Skip to content

AbbVie ABBV Total costs & expenses

Total costs & expenses at other companies

Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$254.56M+42.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$300.47M+36.0%
Amgen logo
AmgenAMGN
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
Incyte logo
IncyteINCY
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$382.49B+3.8%
P/E105.2×+17.4×
P/S6.1×-0.3×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's total costs & expenses?
AbbVie (ABBV) reported total costs & expenses of $11.01B in Q1 2026.
How has AbbVie's total costs & expenses changed year-over-year?
AbbVie's total costs & expenses increased by 14.6% year-over-year, from $9.61B to $11.01B.
What is the long-term trend for AbbVie's total costs & expenses?
Over 4 years (2021 to 2025), AbbVie's total costs & expenses has grown at a 4.8% compound annual growth rate (CAGR), from $38.27B to $46.09B.